4568DAIICHI SANKYO COMPANY,LIMITED¥ --

DAIICHI SANKYO COMPANY,LIMITED

4568

TSE PrimePharmaceuticals

¥ -

View detailed cash flow statement data.

paymentsCash Flow (CF) Summary

Updated: 2026/06/30FY2027 Q1

Operating CF

203.3B JPY

YoY +155.6%

Investing CF

284.2B JPY

YoY +3587.4%

Financing CF

1224.7B JPY

YoY +739.5%

Free CF

487.5B JPY

YoY +230.4%

Cash Flow Trend (5 Years)

Investing CF

Operating CF

Financing CF

5992.6億0

-3777.7億

0000

2123.4億

1392.3億

-862.3億

2022

1145.1億

-2577.8億

-895.9億

2023

5992.6億

-2826.4億

-1235.6億

2024

3341.7億

538.4億

-3777.7億

2025

776.5億

-1482.4億

-978.8億

2026

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

6891.5億3445.7億0-3445.7億-6891.5億

20222023202420252026

waterfall_chartCash Flow Bridge (FY2026 Annual)

Beginning / Ending

Increase

Decrease

8000億7000億6000億5000億4000億

6574.4億

Opening Cash

776.5億

Operating CF

-1482.4億

Investing CF

-978.8億

Financing CF

Other

4889.8億

Closing Cash

Cash Flow Statement

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan